DVA
DAVITA INC.
Company overview
- Market capitalization
- $11.36B
- Employees
- 78,000
- Latest publication
- 2026-09-29
About DAVITA INC.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20082008-12-31 · USD | Q3 20082008-09-30 · USD | Q2 20082008-06-30 · USD | Q1 20082008-03-31 · USD | Q4 20072007-12-31 · USD | Q3 20072007-09-30 · USD | Q2 20072007-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,554,084,000USD | 1,461,010,000USD | 1,447,135,000USD | 1,407,304,000USD | 1,344,724,000USD | 1,354,869,000USD | 1,318,381,000USD | 1,312,735,000USD |
| Cost Of Revenue | 2,551,625,000USD | 1,011,344,000USD | 1,005,648,000USD | 973,286,000USD | 930,209,000USD | 927,503,000USD | 890,243,000USD | 891,013,000USD |
| Gross Profit | 1,002,459,000USD | 449,666,000USD | 441,487,000USD | 434,018,000USD | 414,515,000USD | 427,366,000USD | 428,138,000USD | 421,722,000USD |
| Selling General Administrative | 423,458,000USD | 170,455,000USD | 165,922,000USD | 162,696,000USD | 155,396,000USD | 169,983,000USD | 154,703,000USD | 156,376,000USD |
| General And Administrative Expenses | 423,458,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 423,458,000USD | 238,066,000USD | 233,603,000USD | 215,584,000USD | 208,734,000USD | 232,103,000USD | 215,726,000USD | 160,505,000USD |
| Operating Income | 579,001,000USD | 211,600,000USD | 207,884,000USD | 218,434,000USD | 205,781,000USD | 195,263,000USD | 212,412,000USD | 261,217,000USD |
| Total Other Income Expense Net | -143,991,000USD | -53,745,000USD | -52,024,000USD | -52,333,000USD | -54,203,000USD | -57,322,000USD | -56,437,000USD | -55,253,000USD |
| Interest Expense | 150,256,000USD | 51,665,000USD | 49,543,000USD | 49,346,000USD | 49,340,000USD | 51,993,000USD | 50,159,000USD | 7,680,000USD |
| Income Before Tax | 435,010,000USD | 157,855,000USD | 155,860,000USD | 153,221,000USD | 142,524,000USD | 137,941,000USD | 155,975,000USD | 205,964,000USD |
| Income Tax Expense | 91,787,000USD | 59,490,000USD | 61,950,000USD | 58,270,000USD | 55,590,000USD | 52,224,000USD | 61,520,000USD | 80,940,000USD |
| Equity Method Income Loss | 8,184,000USD | — | — | — | — | — | — | — |
| Net Income | 343,223,000USD | 98,365,000USD | 93,910,000USD | 94,951,000USD | 86,934,000USD | 85,717,000USD | 94,455,000USD | 125,024,000USD |
| Minority Interest | 77,826,000USD | 11,381,000USD | 13,828,000USD | 12,877,000USD | 9,074,000USD | 46,702,000USD | 0USD | 0USD |
| Net Income Applicable To Common Shares | 265,397,000USD | 98,365,000USD | 93,910,000USD | 94,951,000USD | 86,934,000USD | 85,717,000USD | 94,455,000USD | 125,024,000USD |
| Research Development | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Unclassified Operating Expenses | — | 67,611,000USD | 67,681,000USD | 52,888,000USD | 53,338,000USD | 62,120,000USD | 61,023,000USD | 4,129,000USD |
| Net Income From Continuing Ops | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Ebit | — | 211,600,000USD | 207,884,000USD | 221,421,000USD | 210,644,000USD | 195,263,000USD | 212,412,000USD | 261,217,000USD |
| Ebitda | — | 267,844,000USD | 262,854,000USD | 274,313,000USD | 263,455,000USD | 246,655,000USD | 261,642,000USD | 308,275,000USD |
| Depreciation And Amortization | — | 56,244,000USD | 54,970,000USD | 52,892,000USD | 52,811,000USD | 51,392,000USD | 49,230,000USD | 47,058,000USD |
| Reconciled Depreciation | — | 56,244,000USD | 54,970,000USD | 52,892,000USD | 52,811,000USD | 51,392,000USD | 49,230,000USD | 47,058,000USD |
| Discontinued Operations | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20162016-12-31 · USD | FY 20082008-12-31 · USD | FY 20072007-12-31 · USD | FY 20062006-12-31 · USD | FY 20042004-12-31 · USD | FY 20032003-12-31 · USD | FY 20012001-12-31 · USD | FY 19991999-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 14,745,105,000USD | 5,660,173,000USD | 5,264,151,000USD | 4,880,662,000USD | 2,298,595,000USD | 2,046,418,000USD | 1,650,753,000USD | 1,445,351,000USD |
| Cost Of Revenue | 7,431,582,000USD | 3,920,487,000USD | 3,590,344,000USD | 3,390,351,000USD | 1,470,175,000USD | 1,287,652,000USD | 1,100,652,000USD | 993,239,000USD |
| Gross Profit | 3,275,885,000USD | 1,739,686,000USD | 1,673,807,000USD | 1,490,311,000USD | 707,155,000USD | 631,626,000USD | 550,101,000USD | 452,112,000USD |
| Research Development | 0USD | — | — | — | — | — | — | — |
| Selling General Administrative | 1,592,698,000USD | 654,469,000USD | 627,918,000USD | 579,719,000USD | 233,042,000USD | 195,328,000USD | 126,900,000USD | 263,808,000USD |
| Unclassified Operating Expenses | -346,523,000USD | 216,121,000USD | 183,680,000USD | 171,160,000USD | 92,987,000USD | 76,367,000USD | 112,343,000USD | 112,481,000USD |
| Total Operating Expenses | 1,246,175,000USD | 870,590,000USD | 811,598,000USD | 750,879,000USD | 326,029,000USD | 271,695,000USD | 239,243,000USD | 376,289,000USD |
| Operating Income | 2,029,710,000USD | 869,096,000USD | 862,209,000USD | 739,432,000USD | 381,126,000USD | 359,931,000USD | 310,858,000USD | 75,823,000USD |
| Interest Income | 414,116,000USD | — | — | — | — | — | — | — |
| Interest Expense | 414,382,000USD | 199,894,000USD | 156,952,000USD | 489,016,000USD | 44,066,000USD | 113,710,000USD | 71,433,000USD | 399,349,000USD |
| Net Interest Income | -414,382,000USD | — | — | — | — | — | — | — |
| Income Before Tax | 1,488,895,000USD | 609,460,000USD | 627,522,000USD | 475,759,000USD | 361,884,000USD | 288,266,000USD | 240,938,000USD | -181,826,000USD |
| Income Tax Expense | 455,813,000USD | 235,300,000USD | 245,744,000USD | 186,430,000USD | 139,630,000USD | 112,475,000USD | 104,600,000USD | -34,570,000USD |
| Tax Provision | 455,813,000USD | — | — | — | — | — | — | — |
| Net Income | 879,874,000USD | 374,160,000USD | 381,778,000USD | 289,691,000USD | 222,254,000USD | 175,791,000USD | 137,315,000USD | -147,256,000USD |
| Net Income From Continuing Ops | 1,033,082,000USD | — | — | — | — | — | — | — |
| Ebit | 2,247,976,000USD | 881,507,000USD | 862,209,000USD | 739,432,000USD | 381,126,000USD | 359,931,000USD | 310,858,000USD | 75,823,000USD |
| Ebitda | 2,757,473,000USD | 1,098,424,000USD | 1,055,679,000USD | 912,727,000USD | 467,792,000USD | 434,618,000USD | 416,067,000USD | 188,304,000USD |
| Depreciation And Amortization | 509,497,000USD | 216,917,000USD | 193,470,000USD | 173,295,000USD | 86,666,000USD | 74,687,000USD | 105,209,000USD | 112,481,000USD |
| Total Other Income Expense Net | -406,605,000USD | -212,305,000USD | -234,687,000USD | -263,673,000USD | -48,286,000USD | -90,280,000USD | -68,291,000USD | -257,649,000USD |
| Non Operating Income Net Other | 8,734,000USD | — | — | — | — | — | — | — |
| Minority Interest | 153,208,000USD | 47,331,000USD | 46,702,000USD | — | 15,135,000USD | — | 9,260,000USD | — |
| Discontinued Operations | -158,262,000USD | — | — | — | — | — | — | — |
| Net Income Applicable To Common Shares | 879,874,000USD | 374,160,000USD | 381,778,000USD | 289,329,000USD | 222,254,000USD | 175,791,000USD | 136,338,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 17,709,489,000USD | 17,499,365,000USD | 17,480,103,000USD | 17,743,294,000USD | 17,492,958,000USD | 17,119,030,000USD | 17,285,268,000USD | 17,503,737,000USD |
| Cash And Equivalents | 668,963,000USD | — | 676,438,000USD | 705,960,000USD | 708,417,000USD | 438,780,000USD | 794,933,000USD | 1,070,775,000USD |
| Cash And Short Term Investments | 688,877,000USD | 748,706,000USD | 782,050,000USD | 736,484,000USD | 739,431,000USD | 511,943,000USD | 845,997,000USD | 1,091,771,000USD |
| Short Term Investments | 19,914,000USD | 22,303,000USD | 24,303,000USD | 30,524,000USD | 31,014,000USD | 73,163,000USD | 51,064,000USD | 20,996,000USD |
| Long Term Investments | 38,365,000USD | 206,910,000USD | 198,215,000USD | 299,570,000USD | 341,858,000USD | 361,201,000USD | 370,344,000USD | 464,327,000USD |
| Total Current Assets | 4,189,639,000USD | 4,062,683,000USD | 4,058,003,000USD | 4,111,826,000USD | 4,087,828,000USD | 3,636,188,000USD | 3,746,072,000USD | 4,037,000,000USD |
| Other Current Assets | 149,113,000USD | 195,356,000USD | 156,285,000USD | 250,422,000USD | 198,876,000USD | 215,760,000USD | 235,375,000USD | 184,858,000USD |
| Other Non Current Assets | 298,538,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 16,630,051,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 2,855,432,000USD | 2,867,459,000USD | 3,141,634,000USD | 3,017,128,000USD | 2,933,540,000USD | 2,906,782,000USD | 2,973,410,000USD | 2,943,986,000USD |
| Other Current Liabilities | 826,995,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 99,091,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -765,096,000USD | -755,496,000USD | 1,158,438,000USD | 1,528,124,000USD | 1,553,023,000USD | 1,659,969,000USD | 2,091,351,000USD | 2,219,674,000USD |
| Total Equity Including Noncontrolling Interest | 1,079,438,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 10,663,836,000USD | 10,513,597,000USD | 10,163,988,000USD | 10,183,863,000USD | 10,078,805,000USD | 9,559,745,000USD | 9,175,903,000USD | 9,260,331,000USD |
| Net Receivables | 2,467,056,000USD | 2,977,008,000USD | 2,959,041,000USD | 2,985,828,000USD | 3,003,226,000USD | 2,757,963,000USD | 2,530,141,000USD | 2,631,372,000USD |
| Inventory | 151,535,000USD | 141,613,000USD | 160,627,000USD | 139,092,000USD | 146,295,000USD | 150,522,000USD | 134,559,000USD | 128,999,000USD |
| Property Plant Equipment Net | 5,179,363,000USD | 5,151,452,000USD | 5,210,145,000USD | 5,608,481,000USD | 5,193,067,000USD | 5,261,885,000USD | 5,744,885,000USD | 5,357,970,000USD |
| Goodwill | 7,590,966,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 228,817,000USD | 229,020,000USD | 222,125,000USD | 219,673,000USD | 211,687,000USD | 205,263,000USD | 197,431,000USD | 197,854,000USD |
| Accounts Payable | 715,872,000USD | 691,256,000USD | 696,148,000USD | 655,598,000USD | 594,403,000USD | 596,137,000USD | 547,200,000USD | 488,244,000USD |
| Short Term Debt | 439,488,000USD | 544,872,000USD | 534,685,000USD | 494,936,000USD | 611,694,000USD | 599,154,000USD | 681,278,000USD | 700,795,000USD |
| Common Stock | 69,000USD | 69,000USD | 69,000USD | 91,000USD | 91,000USD | 91,000USD | 90,000USD | 90,000USD |
| Retained Earnings | 81,233,000USD | -179,242,000USD | -328,428,000USD | 2,047,216,000USD | 1,896,884,000USD | 1,697,547,000USD | 1,534,630,000USD | 1,275,301,000USD |
| Accumulated Other Comprehensive Income | -58,551,000USD | -86,959,000USD | -122,783,000USD | -116,160,000USD | -137,838,000USD | -226,968,000USD | -310,796,000USD | -162,334,000USD |
| Total Liab | — | 16,451,199,000USD | 16,321,665,000USD | 16,215,170,000USD | 15,939,935,000USD | 15,459,061,000USD | 15,193,917,000USD | 15,284,063,000USD |
| Other Current Liab | — | 1,593,914,000USD | 1,886,442,000USD | 1,840,184,000USD | 1,707,752,000USD | 1,674,914,000USD | 2,415,907,000USD | 1,733,679,000USD |
| Capital Stock | — | 69,000USD | 69,000USD | 91,000USD | 91,000USD | 91,000USD | 90,000USD | 90,000USD |
| Good Will | — | 7,582,313,000USD | 7,545,095,000USD | 7,543,878,000USD | 7,465,769,000USD | 7,415,560,000USD | 7,375,216,000USD | 7,227,630,000USD |
| Cash | — | 726,403,000USD | 757,747,000USD | 705,960,000USD | 708,417,000USD | 438,780,000USD | 794,933,000USD | 1,070,775,000USD |
| Net Debt | — | 12,494,438,000USD | 14,292,242,000USD | 14,171,901,000USD | 12,106,957,000USD | 11,881,558,000USD | 11,271,903,000USD | 11,127,486,000USD |
| Short Long Term Debt | — | 112,653,000USD | 109,201,000USD | 62,921,000USD | 182,442,000USD | 178,648,000USD | 270,867,000USD | 296,255,000USD |
| Short Long Term Debt Total | — | 13,220,841,000USD | 12,874,331,000USD | 12,778,330,000USD | 12,815,374,000USD | 12,320,338,000USD | 12,066,836,000USD | 12,198,261,000USD |
| Property Plant Equipment Gross | — | 11,902,766,000USD | 11,812,279,000USD | 11,830,453,000USD | 11,725,932,000USD | 11,645,448,000USD | 11,597,177,000USD | 11,532,224,000USD |
| Common Stock Shares Outstanding | — | 68,875,000shares | 88,100,000shares | 73,769,000shares | 77,362,000shares | 81,275,000shares | 85,795,000shares | 85,795,000shares |
| Non Current Assets Total | — | 13,436,682,000USD | 13,422,099,999USD | 13,631,468,000USD | 13,405,130,000USD | 13,482,842,000USD | 13,654,216,000USD | 13,466,737,000USD |
| Non Current Liabilities Total | — | 13,583,740,000USD | 13,180,031,000USD | 13,198,042,000USD | 13,006,395,000USD | 12,552,279,000USD | 12,220,507,000USD | 12,340,077,000USD |
| Non Current Liabilities Other | — | 88,853,000USD | 83,516,000USD | 172,195,000USD | 156,486,000USD | 166,515,000USD | 169,588,000USD | 183,030,000USD |
| Non Currrent Assets Other | — | 434,428,000USD | 246,519,999USD | 204,479,000USD | 192,749,000USD | 238,933,000USD | 261,731,000USD | 201,644,000USD |
| Net Working Capital | — | 1,195,224,000USD | 916,369,000USD | 1,094,698,000USD | 1,154,288,000USD | 729,406,000USD | 772,662,000USD | 1,093,014,000USD |
| Unclassified Non Current Assets | — | -167,441,000USD | -246,520,000USD | -449,092,000USD | -192,749,000USD | -238,933,000USD | -295,391,000USD | -201,644,000USD |
| Unclassified Current Liabilities | — | -75,236,000USD | -84,842,000USD | -36,511,000USD | -162,751,000USD | -142,071,000USD | -941,842,000USD | -274,987,000USD |
| Unclassified Non Current Liabilities | — | 2,981,290,000USD | 2,932,527,000USD | 2,841,984,000USD | 2,771,104,000USD | 2,826,019,000USD | 2,875,016,000USD | 2,896,716,000USD |
| Unclassified Equity | — | -489,433,000USD | 1,609,511,000USD | -403,114,000USD | -206,205,000USD | 189,208,000USD | 867,337,000USD | 1,106,527,000USD |
| Other Assets | — | — | 246,520,000USD | 204,479,000USD | 192,749,000USD | 238,933,000USD | -115,020,000USD | 218,956,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | -700,795,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 17,480,103,000USD | 17,285,268,000USD | 16,893,578,000USD | 16,928,252,000USD | 17,121,488,000USD | 16,988,516,000USD | 17,311,394,000USD | 19,110,252,000USD |
| Intangible Assets | 222,125,000USD | 197,431,000USD | 203,224,000USD | 182,687,000USD | 177,693,000USD | 166,585,000USD | 135,684,000USD | 95,329,000USD |
| Other Current Assets | 156,285,000USD | 235,375,000USD | 187,216,000USD | 173,742,000USD | 165,577,000USD | 253,219,000USD | 173,212,000USD | 3,525,000USD |
| Total Liab | 16,321,664,999USD | 15,193,917,000USD | 14,150,228,000USD | 14,703,452,000USD | 14,750,508,000USD | 14,091,736,000USD | 13,811,776,000USD | 14,077,213,000USD |
| Total Stockholder Equity | 1,158,438,001USD | 2,091,351,000USD | 2,743,350,000USD | 2,224,800,000USD | 2,370,980,000USD | 2,896,780,000USD | 3,499,618,000USD | 5,033,039,000USD |
| Other Current Liab | 1,910,801,000USD | 2,415,907,000USD | 1,581,476,000USD | 1,495,123,000USD | 1,369,305,000USD | 1,496,084,000USD | 756,174,000USD | 2,498,522,000USD |
| Common Stock | 69,000USD | 90,000USD | 89,000USD | 90,000USD | 97,000USD | 110,000USD | 126,000USD | 166,000USD |
| Capital Stock | 69,000USD | 90,000USD | 89,000USD | 90,000USD | 97,000USD | 110,000USD | 126,000USD | 166,000USD |
| Retained Earnings | -328,428,000USD | 1,534,630,000USD | 598,288,000USD | 174,487,000USD | 354,337,000USD | 852,537,000USD | 1,431,738,000USD | 2,743,194,000USD |
| Good Will | 7,545,095,000USD | 7,375,216,000USD | 7,112,560,000USD | 7,076,610,000USD | 7,046,241,000USD | 6,919,109,000USD | 6,787,635,000USD | 6,865,477,000USD |
| Other Assets | 246,520,000USD | -115,020,000USD | 725,899,000USD | 1,000USD | 136,677,000USD | 79,501,000USD | 91,520,000USD | 70,732,000USD |
| Cash | 757,747,000USD | 794,933,000USD | 380,063,000USD | 244,086,000USD | 461,900,000USD | 324,958,000USD | 1,102,372,000USD | 323,038,000USD |
| Cash And Equivalents | 676,438,000USD | 794,933,000USD | 380,063,000USD | 244,086,000USD | 461,900,000USD | 324,958,000USD | 1,102,372,000USD | 323,038,000USD |
| Cash And Short Term Investments | 782,050,000USD | 845,997,000USD | 391,673,000USD | 321,779,000USD | 484,210,000USD | 345,059,000USD | 1,113,944,000USD | 325,973,000USD |
| Total Current Assets | 4,058,003,000USD | 3,746,072,000USD | 3,137,906,000USD | 3,155,292,000USD | 3,167,723,000USD | 3,148,724,000USD | 3,690,170,000USD | 8,424,159,000USD |
| Total Current Liabilities | 3,141,634,000USD | 2,973,410,000USD | 2,642,214,000USD | 2,619,747,000USD | 2,398,533,000USD | 2,476,143,000USD | 2,372,098,000USD | 4,891,161,000USD |
| Net Debt | 14,292,242,000USD | 10,590,625,000USD | 10,736,358,000USD | 11,578,404,000USD | 11,513,350,000USD | 10,869,013,000USD | 10,073,574,000USD | 9,779,178,000USD |
| Short Term Debt | 534,685,000USD | 681,278,000USD | 517,698,000USD | 626,805,000USD | 573,387,000USD | 538,038,000USD | 474,620,000USD | 1,929,369,000USD |
| Short Long Term Debt | 109,201,000USD | 270,867,000USD | 123,299,000USD | 231,404,000USD | 179,030,000USD | 168,541,000USD | 130,708,000USD | 1,929,369,000USD |
| Short Long Term Debt Total | 12,874,331,000USD | 12,066,836,000USD | 11,116,421,000USD | 11,822,490,000USD | 11,975,250,000USD | 11,563,468,000USD | 11,519,858,000USD | 10,102,216,000USD |
| Long Term Debt | 10,163,988,000USD | 9,175,903,000USD | 8,268,334,000USD | 8,692,617,000USD | 8,729,150,000USD | 7,917,263,000USD | 7,977,526,000USD | 8,172,847,000USD |
| Long Term Investments | 198,215,000USD | 370,344,000USD | 593,738,000USD | 275,437,000USD | 288,395,000USD | 289,684,000USD | 278,502,000USD | 260,035,000USD |
| Short Term Investments | 24,303,000USD | 51,064,000USD | 11,610,000USD | 77,693,000USD | 22,310,000USD | 20,101,000USD | 11,572,000USD | 2,935,000USD |
| Net Receivables | 2,959,041,000USD | 2,530,141,000USD | 2,415,912,000USD | 2,550,649,000USD | 2,410,508,000USD | 2,438,821,000USD | 2,305,065,000USD | 2,397,018,000USD |
| Inventory | 160,627,000USD | 134,559,000USD | 143,105,000USD | 109,122,000USD | 107,428,000USD | 111,625,000USD | 97,949,000USD | 107,381,000USD |
| Accounts Payable | 696,148,000USD | 547,200,000USD | 514,533,000USD | 479,780,000USD | 402,049,000USD | 434,253,000USD | 403,840,000USD | 463,270,000USD |
| Property Plant Equipment Net | 5,210,145,000USD | 5,744,885,000USD | 5,574,897,000USD | 5,922,639,000USD | 6,304,759,000USD | 6,384,913,000USD | 6,303,431,000USD | 3,393,669,000USD |
| Property Plant Equipment Gross | 11,812,279,000USD | 11,597,177,000USD | 11,334,411,000USD | 11,188,011,000USD | 11,067,894,000USD | 6,384,913,000USD | 6,303,431,000USD | 3,393,669,000USD |
| Accumulated Other Comprehensive Income | -122,782,999USD | -310,796,000USD | -52,083,999USD | -69,186,000USD | -139,247,000USD | -66,154,000USD | -47,498,000USD | -34,924,000USD |
| Common Stock Shares Outstanding | 88,100,000shares | 87,274,000shares | 93,182,000shares | 95,834,000shares | 109,948,000shares | 122,623,000shares | 153,812,064shares | 172,364,581shares |
| Non Current Assets Total | 13,422,100,000USD | 13,654,216,000USD | 13,755,672,000USD | 13,772,960,000USD | 13,953,765,000USD | 13,839,792,000USD | 13,621,224,000USD | 10,686,093,000USD |
| Non Current Liabilities Total | 13,180,030,999USD | 12,220,507,000USD | 12,233,913,000USD | 12,083,705,000USD | 12,351,975,000USD | 11,615,593,000USD | 11,439,678,000USD | 9,186,052,000USD |
| Non Current Liabilities Other | 83,516,000USD | 169,588,000USD | 183,074,000USD | 2,608,301,000USD | 2,791,871,000USD | 2,888,730,000USD | 2,884,609,000USD | 450,669,000USD |
| Non Currrent Assets Other | 246,520,000USD | 261,731,000USD | 271,253,000USD | -467,200,000USD | -694,277,000USD | -730,099,000USD | -461,571,000USD | -490,953,000USD |
| Net Working Capital | 916,369,000USD | 772,662,000USD | 495,692,000USD | 535,545,000USD | 769,190,000USD | 672,581,000USD | 1,318,072,000USD | 3,532,998,000USD |
| Unclassified Non Current Assets | -246,520,000USD | -295,391,000USD | -725,899,000USD | 315,586,000USD | — | — | — | — |
| Unclassified Current Liabilities | -109,201,000USD | -941,842,000USD | -123,299,000USD | -996,152,000USD | -838,990,000USD | -854,096,000USD | -130,708,000USD | -1,929,369,000USD |
| Unclassified Non Current Liabilities | 2,932,526,999USD | 2,875,016,000USD | 3,782,505,000USD | -888,020,000USD | -950,112,000USD | -959,660,000USD | -738,352,000USD | -1,013,205,000USD |
| Unclassified Equity | 1,609,511,000USD | 867,337,000USD | 2,196,967,999USD | 2,119,319,000USD | 2,155,696,000USD | 2,110,177,000USD | 2,115,126,000USD | 2,324,437,000USD |
| Current Deferred Revenue | — | — | 28,507,000USD | 782,787,000USD | 713,752,000USD | 693,323,000USD | 737,464,000USD | — |
| Deferred Long Term Liab | — | — | — | 782,787,000USD | 830,954,000USD | 809,600,000USD | 577,543,000USD | 562,536,000USD |
| Other Liab | — | — | — | 888,020,000USD | 950,112,000USD | 959,660,000USD | 738,352,000USD | 1,013,205,000USD |
| Net Tangible Assets | — | — | — | -5,198,063,000USD | -5,033,594,000USD | -4,372,100,000USD | -3,609,534,000USD | -2,132,723,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | 5,590,262,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 345,637,000USD |
| Stock Based Compensation | 54,189,000USD |
| Deferred Income Tax | 53,431,000USD |
| Other Non Cash Items | -16,721,000USD |
| Change To Account Receivables | -24,197,000USD |
| Change To Inventory | 11,315,000USD |
| Change To Liabilities | -44,897,000USD |
| Change In Working Capital | -168,898,000USD |
| Operating Cash Flow | 810,900,000USD |
| Capital Expenditures | -271,836,000USD |
| Net Investments | -8,485,000USD |
| Unclassified Investing Cash Flow | -53,020,000USD |
| Investing Cash Flow | -333,341,000USD |
| Net Debt Issuance | 2,768,259,000USD |
| Net Common Stock Issuance | -441,666,000USD |
| Other Financing Activities | -18,571,000USD |
| Unclassified Financing Cash Flow | -2,791,550,000USD |
| Financing Cash Flow | -483,528,000USD |
| Effect Of Forex Changes On Cash | 80,000USD |
| Change In Cash | -5,889,000USD |
| End Cash Flow | 751,858,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 275,035,000USD | 331,031,000USD | 309,548,000USD | 275,220,000USD | 162,917,000USD | 349,245,000USD | 295,760,000USD | 299,752,000USD |
| Depreciation | 177,829,000USD | 186,703,000USD | 177,490,000USD | 174,704,000USD | 176,451,000USD | 174,102,000USD | 187,014,000USD | 175,661,000USD |
| Stock Based Compensation | 28,160,000USD | 38,394,000USD | 38,992,000USD | 32,808,000USD | 29,759,000USD | 27,396,000USD | 26,560,000USD | 24,290,000USD |
| Other Non Cash Items | 6,676,000USD | 21,843,000USD | -16,828,000USD | 27,437,000USD | 96,698,000USD | -60,325,000USD | 54,023,000USD | 47,593,000USD |
| Change To Account Receivables | -29,751,000USD | -65,944,000USD | 143,758,999USD | -133,170,999USD | -155,276,000USD | 145,877,000USD | 17,450,000USD | 368,188,000USD |
| Change To Inventory | 20,277,000USD | -20,863,000USD | 10,505,000USD | 5,180,000USD | -14,772,000USD | -2,553,000USD | -1,927,000USD | 20,493,000USD |
| Change In Working Capital | -221,667,000USD | -54,830,000USD | 253,342,000USD | -171,602,000USD | -290,151,000USD | 61,336,000USD | 272,114,000USD | 276,875,000USD |
| Total Cash From Operating Activities | 320,831,000USD | 540,726,000USD | 841,371,000USD | 324,394,000USD | 180,009,000USD | 547,627,000USD | 810,401,000USD | 798,846,000USD |
| Capital Expenditures | -102,018,000USD | -145,430,000USD | -166,085,000USD | -121,091,000USD | -143,258,000USD | -170,657,000USD | -139,046,000USD | -124,725,000USD |
| Free Cash Flow | 218,813,000USD | 395,296,000USD | 675,286,000USD | 203,303,000USD | 36,751,000USD | 376,970,000USD | 671,355,000USD | 674,121,000USD |
| Investments | -4,671,000USD | 4,137,000USD | -262,520,000USD | -67,165,000USD | -162,138,000USD | -247,974,000USD | -146,491,000USD | -161,758,000USD |
| Total Cashflows From Investing Activities | -139,091,000USD | -163,126,000USD | -262,940,000USD | -66,745,000USD | -162,138,000USD | -247,974,000USD | -146,491,000USD | -161,758,000USD |
| Net Borrowings | 346,092,000USD | 31,986,000USD | -24,967,000USD | 529,192,000USD | 287,224,000USD | -76,630,000USD | 571,339,000USD | — |
| Total Cash From Financing Activities | -213,343,000USD | -414,521,000USD | -581,587,000USD | 3,868,000USD | -382,540,000USD | -565,103,000USD | -7,858,000USD | -563,295,000USD |
| Sale Purchase Of Stock | -396,311,000USD | -759,112,000USD | -39,792,000USD | -452,250,000USD | -541,845,000USD | -365,382,000USD | -520,432,000USD | -361,653,000USD |
| Change In Cash | -31,344,000USD | -37,667,000USD | -1,545,000USD | 272,386,000USD | -355,252,000USD | -278,819,000USD | 655,398,000USD | 72,465,000USD |
| Begin Period Cash Flow | 757,747,000USD | 795,414,000USD | 796,959,000USD | 524,573,000USD | 879,825,000USD | 1,158,644,000USD | 503,246,000USD | 430,781,000USD |
| End Period Cash Flow | 726,403,000USD | 757,747,000USD | 795,414,000USD | 796,959,000USD | 524,573,000USD | 879,825,000USD | 1,158,644,000USD | 503,246,000USD |
| Other Cashflows From Investing Activities | 3,830,000USD | 2,935,000USD | -51,258,000USD | 56,465,000USD | 11,986,000USD | 8,051,000USD | 5,158,000USD | 9,464,000USD |
| Other Cashflows From Financing Activities | -165,510,000USD | 334,301,000USD | -1,350,827,000USD | -54,352,000USD | -127,919,000USD | -143,544,000USD | -58,765,000USD | -80,319,000USD |
| Unclassified Operating Cash Flow | 54,798,000USD | 17,585,000USD | 78,827,000USD | -14,173,000USD | 4,335,000USD | — | -25,070,000USD | -25,325,000USD |
| Unclassified Investing Cash Flow | -36,232,000USD | -24,768,000USD | 216,923,000USD | 65,046,000USD | 131,272,000USD | 162,606,000USD | 133,888,000USD | 115,261,000USD |
| Unclassified Financing Cash Flow | 2,386,000USD | -21,696,000USD | 833,999,000USD | -18,722,000USD | — | 20,453,000USD | — | -121,323,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,078,716,000USD | 1,250,737,000USD | 691,535,000USD | 781,643,000USD | 1,211,762,000USD | 994,677,000USD | 1,021,294,000USD | 333,040,000USD |
| Depreciation | 715,348,000USD | 723,860,000USD | 745,443,000USD | 732,602,000USD | 680,615,000USD | 630,435,000USD | 615,152,000USD | 591,035,000USD |
| Stock Based Compensation | 139,953,000USD | 102,788,000USD | 112,375,000USD | 95,427,000USD | 102,209,000USD | 91,458,000USD | 67,850,000USD | 73,061,000USD |
| Other Non Cash Items | 129,150,000USD | 32,314,000USD | 354,497,000USD | 30,466,000USD | 16,446,000USD | 125,782,000USD | 239,477,000USD | 401,945,000USD |
| Change To Account Receivables | -210,632,000USD | -29,766,000USD | 172,361,000USD | -148,394,000USD | -138,140,000USD | -21,087,000USD | -79,957,000USD | -81,176,000USD |
| Change To Inventory | -19,950,000USD | 17,942,000USD | -32,132,000USD | -757,000USD | 5,720,000USD | -12,349,000USD | 10,158,000USD | 73,505,000USD |
| Change In Working Capital | -263,241,000USD | -29,821,000USD | 194,535,000USD | 101,000USD | -140,639,000USD | -104,172,000USD | 86,859,000USD | 98,899,000USD |
| Total Cash From Operating Activities | 1,886,500,000USD | 2,022,038,000USD | 2,059,031,000USD | 1,564,570,000USD | 1,930,876,000USD | 1,979,028,000USD | 2,072,355,000USD | 1,771,640,000USD |
| Capital Expenditures | -575,864,000USD | -555,443,000USD | -567,985,000USD | -603,429,000USD | -641,465,000USD | -674,541,000USD | -766,546,000USD | -987,138,000USD |
| Free Cash Flow | 1,310,636,000USD | 1,466,595,000USD | 1,491,046,000USD | 961,141,000USD | 1,289,411,000USD | 1,304,487,000USD | 1,305,809,000USD | 784,502,000USD |
| Investments | 29,700,000USD | -771,429,000USD | -816,768,000USD | -83,602,000USD | -14,695,000USD | -18,956,000USD | -14,645,000USD | 14,446,000USD |
| Total Cashflows From Investing Activities | -654,949,000USD | -771,429,000USD | -771,800,000USD | -630,347,000USD | -784,733,000USD | -825,371,000USD | 2,995,340,000USD | -1,005,643,000USD |
| Net Borrowings | 823,435,000USD | 1,109,097,000USD | -552,615,000USD | -11,279,000USD | 754,255,000USD | -63,529,000USD | -2,080,191,000USD | 694,777,000USD |
| Total Cash From Financing Activities | -1,374,780,000USD | -816,937,000USD | -1,170,495,000USD | -1,121,128,000USD | -1,082,966,000USD | -1,846,777,000USD | -4,696,450,000USD | -625,354,000USD |
| Sale Purchase Of Stock | -1,792,999,000USD | -1,385,932,000USD | -272,219,000USD | -802,228,000USD | -1,598,627,000USD | -1,459,417,000USD | -2,383,816,000USD | -1,161,511,000USD |
| Change In Cash | -122,078,000USD | 415,191,000USD | 125,645,000USD | -215,971,000USD | 53,170,000USD | -706,928,000USD | 793,298,000USD | -103,500,000USD |
| Begin Period Cash Flow | 879,825,000USD | 464,634,000USD | 338,989,000USD | 554,960,000USD | 501,790,000USD | 1,208,718,000USD | 415,420,000USD | 518,920,000USD |
| End Period Cash Flow | 757,747,000USD | 879,825,000USD | 464,634,000USD | 338,989,000USD | 554,960,000USD | 501,790,000USD | 1,208,718,000USD | 415,420,000USD |
| Other Cashflows From Investing Activities | 35,713,000USD | 32,542,000USD | 35,523,000USD | 120,762,000USD | 63,663,000USD | 53,278,000USD | 3,879,981,000USD | 153,851,000USD |
| Other Cashflows From Financing Activities | -374,687,000USD | -560,555,000USD | -362,561,000USD | -326,198,000USD | -238,594,000USD | -217,983,000USD | -243,825,000USD | -177,224,000USD |
| Unclassified Operating Cash Flow | 86,574,000USD | -57,840,000USD | -39,354,000USD | -75,669,000USD | 60,483,000USD | 240,848,000USD | 41,723,000USD | 273,660,000USD |
| Unclassified Investing Cash Flow | -144,498,000USD | 522,901,000USD | 577,430,000USD | -64,078,000USD | -192,236,000USD | -185,152,000USD | -103,450,000USD | -186,802,000USD |
| Unclassified Financing Cash Flow | -30,529,000USD | 20,453,000USD | 16,900,000USD | 286,523,000USD | 244,033,000USD | 147,270,000USD | — | 215,045,000USD |
| Issuance Of Capital Stock | — | 20,453,000USD | 16,900,000USD | 18,577,000USD | — | — | 11,382,000USD | — |
| Change To Liabilities | — | — | — | 172,268,000USD | -110,493,000USD | 14,664,000USD | 146,903,000USD | -133,922,000USD |
| Dividends Paid | — | — | — | -267,946,000USD | -244,033,000USD | -253,118,000USD | -11,382,000USD | -196,441,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -186,905,000USD | 63,177,000USD | -693,120,000USD | 371,245,000USD | 140,643,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2024Yearly · 2024-12-31 | Segment | Other Operating Segments With Intersegment | 1,510,490,000 | USD | 0000927066-25-000012 |
| FY 2024Yearly · 2024-12-31 | Segment | USDialysis And Related Lab Services With Intersegment | 11,390,717,000 | USD | 0000927066-25-000012 |
| Q3 2024Quarterly · 2024-09-30 | Segment | All Other Segments | 373,730,000 | USD | 0000927066-24-000179 |
| Q3 2024Quarterly · 2024-09-30 | Segment | USDialysis And Related Lab Services | 2,889,860,000 | USD | 0000927066-24-000179 |
| Q2 2024Quarterly · 2024-06-30 | Segment | All Other Segments | 358,637,000 | USD | 0000927066-24-000128 |
| Q2 2024Quarterly · 2024-06-30 | Segment | USDialysis And Related Lab Services | 2,828,085,000 | USD | 0000927066-24-000128 |
| Q1 2024Quarterly · 2024-03-31 | Segment | All Other Segments | 338,858,000 | USD | 0000927066-24-000090 |
| Q1 2024Quarterly · 2024-03-31 | Segment | USDialysis And Related Lab Services | 2,731,697,000 | USD | 0000927066-24-000090 |
| FY 2023Yearly · 2023-12-31 | Segment | Other Operating Segments With Intersegment | 1,299,223,000 | USD | 0000927066-25-000012 |
| FY 2023Yearly · 2023-12-31 | Segment | USDialysis And Related Lab Services With Intersegment | 10,936,998,000 | USD | 0000927066-25-000012 |
| Q4 2023Quarterly · 2023-12-31 | Segment | All Other Segments | 358,355,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Segment | USDialysis And Related Lab Services | 2,787,392,000 | USD | Legacy provider |
| Q3 2023Quarterly · 2023-09-30 | Segment | All Other Segments | 360,315,000 | USD | 0000927066-24-000179 |
| Q3 2023Quarterly · 2023-09-30 | Segment | USDialysis And Related Lab Services | 2,761,017,000 | USD | 0000927066-24-000179 |
| Q2 2023Quarterly · 2023-06-30 | Segment | All Other Segments | 290,115,000 | USD | 0000927066-24-000128 |
| Q2 2023Quarterly · 2023-06-30 | Segment | USDialysis And Related Lab Services | 2,710,254,000 | USD | 0000927066-24-000128 |
| Q1 2023Quarterly · 2023-03-31 | Segment | All Other Segments | 282,586,000 | USD | 0000927066-24-000090 |
| Q1 2023Quarterly · 2023-03-31 | Segment | USDialysis And Related Lab Services | 2,590,113,000 | USD | 0000927066-24-000090 |
| FY 2022Yearly · 2022-12-31 | Segment | Other Operating Segments With Intersegment | 1,101,326,000 | USD | 0000927066-25-000012 |
| FY 2022Yearly · 2022-12-31 | Segment | USDialysis And Related Lab Services With Intersegment | 10,599,809,000 | USD | 0000927066-25-000012 |
| Q4 2022Quarterly · 2022-12-31 | Segment | All Other Segments | 281,188,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Segment | USDialysis And Related Lab Services | 2,635,700,000 | USD | Legacy provider |
| FY 2021Yearly · 2021-12-31 | Segment | All Other Segments | 1,042,630,000 | USD | 0000927066-24-000013 |
| FY 2021Yearly · 2021-12-31 | Segment | USDialysis And Related Lab Services | 10,576,167,000 | USD | 0000927066-24-000013 |
| FY 2020Yearly · 2020-12-31 | Segment | All Other Segments | 1,035,955,000 | USD | 0000927066-23-000011 |
| FY 2020Yearly · 2020-12-31 | Segment | USDialysis And Related Lab Services | 10,514,649,000 | USD | 0000927066-23-000011 |
| FY 2019Yearly · 2019-12-31 | Segment | All Other Segments | 957,898,000 | USD | 0000927066-22-000012 |
| FY 2019Yearly · 2019-12-31 | Segment | USDialysis And Related Lab Services | 10,430,581,000 | USD | 0000927066-22-000012 |
| FY 2018Yearly · 2018-12-31 | Segment | All Other Segments | 1,161,852,000 | USD | 0000927066-21-000008 |
| FY 2018Yearly · 2018-12-31 | Segment | USDialysis And Related Lab Services | 10,242,999,000 | USD | 0000927066-21-000008 |
| FY 2017Yearly · 2017-12-31 | Segment | All Other Segments | 1,571,745,000 | USD | 0000927066-20-000014 |
| FY 2017Yearly · 2017-12-31 | Segment | USDialysis And Related Lab Services | 9,304,889,000 | USD | 0000927066-20-000014 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.